Edition:
United States

Antisense Therapeutics Ltd (ANP.AX)

ANP.AX on Australia Stock Exchange

0.04AUD
30 Sep 2016
Change (% chg)

$-0.00 (-10.00%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
236,576
Avg. Vol
167,936
52-wk High
$0.10
52-wk Low
$0.03

ANP.AX

Chart for ANP.AX

About

Antisense Therapeutics Limited (Antisense Therapeutics) is an Australia-based antisense technology company. The Company is engaged in the research and development of antisense pharmaceuticals. The Company's segments include ATL 1102 - Multiple Sclerosis and ATL 1103 - Growth and Sight Disorders. The Company's product pipeline... (more)
No analyst recommendations are available for ANP.AX.

Overall

Beta: 0.51
Market Cap(Mil.): $7.06
Shares Outstanding(Mil.): 176.51
Dividend: --
Yield (%): --

Financials

  ANP.AX Industry Sector
P/E (TTM): -- 43.83 36.83
EPS (TTM): -0.01 -- --
ROI: -43.10 -0.29 13.93
ROE: -43.10 -2.99 14.84

Earnings vs. Estimates

No consensus analysis data available.